Skip to content

Released Apr 29, 2015, after the close

10-K filed Apr 29, 2015, 119 days after period end · 0001564590-15-003012

Q4 2014 · 10-K
Revenue$100.28M−5.3% vs Q4 2013−0.7% vs Q3 2014
Net Income-$5.80MN/M vs Q4 2013N/M vs Q3 2014
EPS Diluted-$0.31N/M vs Q4 2013N/M vs Q3 2014
Gross Profit$78,827,000+9.8%
Operating Income$3,953,000N/M
Operating Cash Flowderived$15,198,000+0.4%
Free Cash Flowderived$8,453,000−13.6%
Margins · derived
Gross margin78.6%+10.8 pt vs Q4 2013
Operating margin3.9%+13.5 pt vs Q4 2013
Net margin-5.8%+4.1 pt vs Q4 2013

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2014Q4 2013Q4 2012Q4 2011
Revenue$100.28M$105.89M$115.61M$118.64M
Net Income-$5.80M-$10.41M$22.95M$7.89M
EPS Diluted-$0.31-$0.58$1.17$0.42

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR